Capecitabine in the treatment of colorectal cancer
Zeuli, M.; Pino, M.S.; Cognetti, F.
Tumori 87(1 Suppl 1: S55-S56
2001
ISSN/ISBN: 0300-8916 PMID: 11300027 Document Number: 526304
Document emailed within 1 workday
Related Documents
Karacetin, D.; Yalcin, B.; Okten, B.; Ozturk, S.; Maral, O.; Incekara, O. 2009: Capecitabine and oxaliplatin (XELOX) as first-line treatment for patients with metastatic colorectal cancer Journal of BUON: Official Journal of the Balkan Union of Oncology 14(4): 605-608Cokmert, S.; Demir, L.; Can, A.; Akyol, M.; Vedat Bayoglu, I.; Dirican, A.; Kucukzeybek, Y.; Erten, C.; Oktay Tarhan, M. 2014: Capecitabine-related increased mean corpuscular volume of red blood cell may be a predictive marker of treatment response and survival in patients with metastatic colorectal cancer Journal of BUON: Official Journal of the Balkan Union of Oncology 19(1): 75-82
Koukourakis, G.; Kouloulias, V.; Zacharias, G.; Koukourakis, M. 2010: Capecitabine chemotherapy for metastatic colorectal cancer. Chemical structure, combinations and efficacy Journal of Buon: Official Journal of the Balkan Union of Oncology 15(4): 652-659
Vrdoljak, E.; Omrcen, T.; Boban, M.; Hrepic, D. 2008: Capecitabine and mitomycin-C in the therapy of pretreated patients with metastatic colorectal cancer: single center retrospective study with 36 patients Journal of BUON: Official Journal of the Balkan Union of Oncology 13(4): 513-518
Ararat, E.; Sahin, I.; Altundag, K. 2011: How addition of capecitabine might be more beneficial in the neoadjuvant treatment of breast cancer Journal of Buon: Official Journal of the Balkan Union of Oncology 16(2): 377
Liu, X.; Song, S.; Guan, Z.; Wu, S.; Duan, Y.; Yu, J.; Yang, L. 2002: Capecitabine (xeloda) in the treatment of relapsed and metastatic breast cancer Zhonghua Zhong Liu Za Zhi 24(1): 71-73
Jin, J.; Li, Y-Xiong.; Liu, Y-Ping.; Wang, W-Hu.; Li, T.; Li, N.; Song, Y-wen. 2006: Phase I study of postoperative concurrent chemoradiation with capecitabine as adjuvant treatment for stage II/III operable rectal cancer Zhonghua Zhong Liu Za Zhi 28(5): 393-396
Aaltonen, L.A.; Sankila, R.; Mecklin, J.P.; Järvinen, H.; Pukkala, E.; Peltomäki, P.; de la Chapelle, A. 1994: A novel approach to estimate the proportion of hereditary nonpolyposis colorectal cancer of total colorectal cancer burden Cancer Detection and Prevention 18(1): 57-63
Zhang, X-dong.; Shen, L.; Li, Y.; Li, J.; Yang, B-qin.; Jin, M-lin. 2003: The evaluation of LFH or LFPH in the treatment of advanced cancer of gastric cardia and colorectal cancer Zhonghua Zhong Liu Za Zhi 25(3): 289-291
Cerea, G.; Vaghi, M.; Ardizzoia, A.; Villa, S.; Bucovec, R.; Mengo, S.; Gardani, G.; Tancini, G.; Lissoni, P. 2003: Biomodulation of cancer chemotherapy for metastatic colorectal cancer: a randomized study of weekly low-dose irinotecan alone versus irinotecan plus the oncostatic pineal hormone melatonin in metastatic colorectal cancer patients progressing on 5-fluorouracil-containing combinations Anticancer Research 23(2c): 1951-1954
Ishida, H.; Fujioka, M.; Ohsawa, T.; Takeuchi, I.; Nakada, H.; Ishizuka, N.; Yokoyama, M.; Inokuma, S.; Yamada, H.; Odaka, A.; Hoshino, T.; Murata, N.; Hashimoto, D.; Matsumoto, Y.; Miura, T. 2001: Effect of peroral doxifluridine plus hepatic arterial infusion for synchronous liver metastasis of colorectal cancer--correlation with the expression of thymidine phosphorylase and dihydropyrimidine dehydrogenase in primary colorectal cancer lesions Gan to Kagaku Ryoho. Cancer and ChemoTherapy 28(11): 1624-1627
Veerasarn, V.; Boonnuch, W.; Chinswangwatanakul, V.; Lohsiriwat, D.; Mahamadsolaeh, P. 2008: Preoperative chemoradiation for locally advanced rectal cancer with capecitabine 2,000 mg/m2/day Journal of the Medical Association of Thailand 91(10): 1583-1588
Karczmarek-Borowska, B.; Drzymała, M.łg.; Golon, K. 2014: Hepatotoxicity of acetaminophen in a patient treated with capecitabine due to breast cancer Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 36(215): 348-351
Hashimoto, T.; Yokoyama, M.; Kimura, S.; Usuba, O.; Toyono, M. 2013: A case of relapsed colon cancer successfully treated by capecitabine Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(4): 523-527
Tsuyuki, S.; Kawaguchisakita, N.; Tsubota, Y.; Ukikusa, M.; Kohno, Y. 2010: More effective positioning of capecitabine for advanced and metastatic breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(4): 649-653
Påhlman, L. 2000: Treatment of colorectal cancer Annales Chirurgiae et Gynaecologiae 89(3): 216-220
Matsuda, C.; Tamagawa, H.; Nishikawa, K.; Deguchi, T.; Kawata, J.; Iwase, K.; Takagi, M.; Fukui, A.; Nezu, R.; Tanaka, Y. 2013: Study of tolerability of capecitabine in postoperative adjuvant chemotherapy in colon cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(3): 327-330
Qian, J.; Qin, S.-k.; Mei, J.-f.; Chen, Y.-x.; Shao, Z.-j.; He, Z.-m. 2004: Oxaliplatin plus capecitabine as a second line chemotherapy for patients with advanced gastric cancer Zhonghua Zhong Liu Za Zhi 26(12): 746-748
Díaz-Cantón, E.A.; Pazdur, R. 1996: Medical treatment of colorectal cancer Medicina 56(4): 414-422
Díaz-Cantón, E.A.; Pazdur, R. 1996: Medical treatment of colorectal cancer Medicina 56(4): 414-422